Women's Health News

RSS

Key recommendations for better services for women with secondary breast cancer

The support provided for women with secondary breast cancer is inadequate and urgent steps are needed to provide better services for patients with this progressive incurable disease, which kills half a million women worldwide every year. Those are the key recommendations to emerge from a trio of papers in the September issue of the European Journal of Cancer Care.

16 Sep 2010

Aetna supports landmark study on BRCA testing

Testing is available to help identify if a woman is likely to face one of her gender's worst fears: inherited breast and ovarian cancer. But significant questions have been raised among doctors and public health agencies about whether these tests are being offered to the women who can most benefit - consistent with the evidence-based guidelines for this testing - and whether the information learned from testing is being put to best use.

16 Sep 2010

Moores UCSD Cancer Center receives Breast Imaging Center of Excellence certificate from ACR

Moores UCSD Cancer Center at the University of California, San Diego has been designated a Breast Imaging Center of Excellence by the American College of Radiology.

16 Sep 2010

Maternal mortality worldwide declines by over one-third since 1990, U.N. report says

Maternal mortality has declined by more than one-third since 1990, according to a report from U.N. agencies released on Wednesday, Agence France-Presse reports. But the agencies warned that the rate of progress was too slow and that the decline still misses the maternal mortality Millennium Development Goal target of a three-quarters cut (9/15).

16 Sep 2010

Consuming alcohol after diagnosis increases breast cancer recurrence risk: Study

In the Life After Cancer Epidemiology (LACE) study, 1,897 participants diagnosed with early-stage breast cancer between 1997 and 2000 and recruited on average 2 years post-breast cancer diagnosis were evaluated for the association between alcohol intake and breast cancer recurrence and death.

16 Sep 2010

Spirogen, Celtic Therapeutics announces initiation of Phase II ovarian cancer trial with SG2000

Spirogen Limited and Celtic Therapeutics Holdings LP announced today the commencement of a Phase II clinical trial of SG2000 in ovarian cancer. The trial is being sponsored by the National Cancer Institute of the USA, and is now actively recruiting patients for treatment.

16 Sep 2010

Calm men preferred by women: Study

According to a new study, women prefer calm men to stressed ones. Researchers at the University of Abertay Dundee in Scotland found that women were more attracted to calm, collected men with lower levels of the stress hormone cortisol coursing through their systems, than men who are chronically stressed. The study was published in the Proceedings of the Royal Society B journal. The researchers also found that there was no clear association between attractiveness and high levels of testosterone as was thought before.

16 Sep 2010

Maternal mortality decreases by 34%, but 1000 still die a day

The number of women dying due to complications during pregnancy and childbirth has decreased by 34% from an estimated 546 000 in 1990 to 358 000 in 2008, according to a new report, Trends in maternal mortality, released by the World Health Organization (WHO), the United Nations Children's Fund (UNICEF), the United Nations Population Fund (UNFPA) and the World Bank.

15 Sep 2010

Survey reveals inadequate provision for women with secondary breast cancer

57% of breast care nurses who took part in a UK survey for the charity Breast Cancer Care feel that there is inadequate provision for women with secondary breast cancer, a progressive incurable disease that kills half a million women worldwide every year after the cancer spreads to other organs. Many said that they felt ill equipped to care for women with secondary breast cancer and that their time was dominated by meeting the needs of women with primary breast cancer.

15 Sep 2010

Compandia is now CompanDX

Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.

15 Sep 2010

Unsuccessful gum-disease treatment linked to preterm birth

A collaboration led by a periodontal researcher from the University of Pennsylvania School of Dental Medicine has found a possible link between the success of gum-disease treatment and the likelihood of giving birth prematurely, according to a study published in the journal BJOG: An International Journal of Obstetrics and Gynaecology.

15 Sep 2010

Hormone melatonin improves egg quality in IVF

Poor egg (oocyte) quality is an important cause of female infertility. Low quality eggs may have several problems, for example they may not divide properly, or they may be missing certain chromosomes. Egg quality also declines with age, and certain medical conditions, such as PolyCystic Ovary Syndrome, can lead to poor quality eggs.

15 Sep 2010

Pregnant women should get immunized against flu

There will be only one flu shot needed this year and pregnant women should make sure they're at the front of the line to get it.

15 Sep 2010

USF receives grant for studying ways to protect fetal brain from maternal infection

University of South Florida (USF) neuroscientists have been awarded a $400,000 federal grant to study ways of protecting the developing fetal brain from the damaging effects of maternal infections, a suspected cause for certain types of autism.

15 Sep 2010

Early alcohol, tobacco exposure may delay puberty in girls: Study

The list of possible health effects from an early introduction to alcohol and tobacco use has just gotten longer. A new study suggests that early drinking and smoking might delay onset of puberty in girls.

15 Sep 2010

Professor Nygren reviews current state of IVF safety

Now a review by the Chair of the international body which collects data on IVF concludes that IVF is generally safe, although he stresses that patients need to be made aware of the slight risks, and that we need to continue to monitor the results of the technique.

14 Sep 2010

U of A team on cusp of developing simple predictive test for preeclampsia

A team of researchers from the University of Alberta is on the cusp of developing a simple test to accurately predict which women will develop preeclampsia - a condition that affects 4 million women a year and can result in the deaths of both mothers and their babies.

14 Sep 2010

U-Systems granted EU marketing approval for somo•v Automated Breast Ultrasound system

U-Systems, the leader in automated breast ultrasound, today announced that it has received approval to market the somo•v™ Automated Breast Ultrasound (ABUS) system as an adjunct to mammography for screening asymptomatic women for breast cancer in the European Union.

13 Sep 2010

Regis to kick off Clip for the Cure campaign to raise money, awareness for breast cancer research

In October, Regis Corporation, the global leader in the haircare industry, will kick off its annual Clip for the Cure, a month-long campaign to raise money and awareness for breast cancer research in support of National Breast Cancer Awareness Month. To date, the company's dedicated stylists and clients have raised more than $6.5 million for the cause.

13 Sep 2010

FDA approves FASLODEX 500mg dose for metastatic breast cancer in postmenopausal women

AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has approved the 500mg dose of FASLODEX® (fulvestrant) Injection, replacing the previously approved monthly dose of 250mg, for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

13 Sep 2010

Women's Health News

Key recommendations for better services for women with secondary breast cancer

Aetna supports landmark study on BRCA testing

Moores UCSD Cancer Center receives Breast Imaging Center of Excellence certificate from ACR

Maternal mortality worldwide declines by over one-third since 1990, U.N. report says

Consuming alcohol after diagnosis increases breast cancer recurrence risk: Study

Spirogen, Celtic Therapeutics announces initiation of Phase II ovarian cancer trial with SG2000

Calm men preferred by women: Study

Maternal mortality decreases by 34%, but 1000 still die a day

Survey reveals inadequate provision for women with secondary breast cancer

Compandia is now CompanDX

Unsuccessful gum-disease treatment linked to preterm birth

Hormone melatonin improves egg quality in IVF

Pregnant women should get immunized against flu

USF receives grant for studying ways to protect fetal brain from maternal infection

Early alcohol, tobacco exposure may delay puberty in girls: Study

Professor Nygren reviews current state of IVF safety

U of A team on cusp of developing simple predictive test for preeclampsia

U-Systems granted EU marketing approval for somo•v Automated Breast Ultrasound system

Regis to kick off Clip for the Cure campaign to raise money, awareness for breast cancer research

FDA approves FASLODEX 500mg dose for metastatic breast cancer in postmenopausal women

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News